STAU2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.839400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.240000E-01
Normal-vs-Stage2
7.283400E-01
Normal-vs-Stage3
1.903990E-01
Normal-vs-Stage4
5.522400E-01
Stage1-vs-Stage2
8.555200E-01
Stage1-vs-Stage3
1.214970E-01
Stage1-vs-Stage4
3.041600E-01
Stage2-vs-Stage3
1.647040E-01
Stage2-vs-Stage4
1.175400E-01
Stage3-vs-Stage4
1.012000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.588600E-01
Normal-vs-AfricanAmerican
9.293000E-01
Normal-vs-Asian
7.160800E-01
Caucasian-vs-AfricanAmerican
5.474000E-01
Caucasian-vs-Asian
8.161400E-01
AfricanAmerican-vs-Asian
5.751600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.271400E-01
Normal-vs-Female
7.348800E-01
Male-vs-Female
8.061600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.976800E-01
Normal-vs-Age(41-60Yrs)
8.192000E-01
Normal-vs-Age(61-80Yrs)
6.479800E-01
Normal-vs-Age(81-100Yrs)
2.933600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.102200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.336800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.262200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.583670E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.080100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.901600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.272200E-01
Normal-vs-Daily Drinker
7.085200E-01
Normal-vs-Weekly Drinker
2.669800E-01
Normal-vs-Occasional Drinker
7.363000E-01
Normal-vs-Social Drinker
9.289600E-01
Non Drinker-vs-Daily Drinker
5.987600E-01
Non Drinker-vs-Weekly Drinker
6.276000E-01
Non Drinker-vs-Occasional Drinker
3.464000E-02
Non Drinker-vs-Social Drinker
2.517000E-01
Daily Drinker-vs-Weekly Drinker
4.647800E-01
Daily Drinker-vs-Occasional Drinker
1.775620E-01
Daily Drinker-vs-Social Drinker
5.857000E-01
Weekly Drinker-vs-Occasional Drinker
3.276000E-02
Weekly Drinker-vs-Social Drinker
1.769030E-01
Occasional Drinker-vs-Social Drinker
4.497800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.782380E-01
Normal-vs-Grade 2
4.005600E-02
Normal-vs-Grade 3
4.463600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.007400E-01
Grade 1-vs-Grade 3
9.545400E-01
Grade 1-vs-Grade 4
1.782380E-01
Grade 2-vs-Grade 3
6.015000E-01
Grade 2-vs-Grade 4
4.005600E-02
Grade 3-vs-Grade 4
4.463600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.395000E-01
Normal-vs-NonDiabetic
7.304400E-01
Diabetic-vs-NonDiabetic
7.414000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.308400E-01
Normal-vs-NoPancreatitis
7.356200E-01
Pancreatitis-vs-NoPancreatitis
8.272800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.185200E-01
Normal-vs-N1
7.784400E-01
N0-vs-N1
9.624400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.770000E-01
Normal-vs-TP53-NonMutant
7.638200E-01
TP53-Mutant-vs-TP53-NonMutant
2.842400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
